Aastrom Biosciences (ASTM) Reports a Q1 Loss
More News related to ASTM
- Updates and Results From Aastrom's Vascular Program Presented at an American Heart Association Satellite Symposium
- Interim Results From Aastrom's IMPACT-DCM Cardiac Trial Presented at The American Heart Association Meeting
- Trading Outlook for Hard To Treat Diseases Inc. Issued by InvestorSoup.com
- Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
- Aastrom Biosciences (ASTM) Reports a Q1 Loss
More News related to Earnings
- Green Mountain (GMCR) Will Likely Win Diedrich Coffee (DDRX) Bidding War - Analyst
- FBR Capital Raises Estimates & PT on Trina Solar (TSL) following 3Q09 results
- Broadpoint.AmTech Reiterates a 'Buy' on Precision Castparts (PCP); Issues Top Ten for Owning Shares
- Citi Recommends Stocks in Qatar, UAE, Egypt; Believes Middle East Will 'Catch Up' to Emerging Markets
- Broadpoint.AmTech Maintains a 'Buy' on First Solar (FSLR); Lowers PT and Estimates
Aastrom Biosciences, Inc. (Nasdaq: ASTM) reports a Q1 loss of $0.02 compared to a $0.03 profit for the same period last year.
Total revenues for the quarter ended September 30, 2009, consisting of product sales, were $73,000 compared to total revenues of $27,000 for the same period in fiscal year 2009.
[SM]
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
